Presented by
IVBM Event Coverage
Community Collaboration Key to Inclusive Clinical Trial Design: Amir Fathi, MD
Community partnerships and trial design reforms can reduce travel barriers and improve underserved patient representation, said Amir Fathi, MD.
Overcoming Mistrust in Clinical Trial Enrollment Through Community Resources: Susan Vadaparampil, PhD, MPH
Patient navigators, community health workers, and/or peer advocates serve as trusted community resources for patients, Susan Vadaparampil, PhD, MPH, says.
Catchment Areas Shape Diversity and Access in Oncology Trials: Amir Fathi, MD
Catchment areas, access, and partnerships influence diversity in oncology trials, Amir Fathi, MD, explains at a Boston IVBM panel.
Medically Integrated Dispensing Strengthens Oncology Care Through Real-Time EMR Access: Sam Abdelghany, PharmD, BCOP, MHA
Medically integrated dispensing improves oncology treatment coordination through EMR-based care, but payer restrictions remain a key barrier.
Medically Integrated Dispensing Helps Prevent Oncology Care Fragmentation: Katherine Tobon, PharmD, BCOP
Medically integrated dispensing is well-positioned to support value-based oncology care models and closer patient follow-up and monitoring, says Katherine Tobon, PharmD, BCOP.
MID Models Reduce Adverse Events, Lower Costs in Oncology: Kenneth Komorny, PharmD, BCPS
MID in oncology also enhances treatment adherence and improves patient outcomes, according to Kenneth Komorny, PharmD, BCPS.
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
Medically integrated dispensing (MID) improves monitoring and supports value-based care, but startup costs and payer barriers remain, notes Katherine Tobon, PharmD, BCOP.
Linking Community Screening Programs to Cancer Centers Boosts Trial Diversity: Susan Vadaparampil, PhD, MPH
Susan Vadaparampil, PhD, MPH, highlights disparities in cancer outcomes and trial enrollment but underscores that linking community screening programs with cancer centers may help.
New Multiple Myeloma Therapies Offer Hope for Potential Cure: Ameet Patel, MD
Targeted therapies, bispecifics, and CAR T-cell therapies are giving patients with multiple myeloma hope for long-term remission or a potential cure.
Pharmacy Innovations That Improve Care Quality, Cut Costs: A Q&A With Jose Guzman Garcia, PharmD, MHA, BCCCP
Jose Guzman Garcia, PharmD, MHA, BCCCP, discusses key pharmacy initiatives at UC Davis Health.
AI Can Help Community and Academic Oncology Practices: Tina Bhatnagar, DO
Bhavana (Tina) Bhatnagar, DO, discusses the transformative role of AI in enhancing patient care at West Virginia University Cancer Institute.
Invest in Human Capital to Improve Breast Cancer Care Delays: Adam Brufsky, MD, PhD
Delays in breast cancer diagnosis and treatment highlight the need for improved human capital investment in health care systems, explains Adam Brufsky, MD, PhD.
Team-Based Cancer Care Vital in the Community: Danielle Roman, PharmD, BCOP
Danielle Roman, PharmD, BCOP, explains why a collaborative, team-based approach is essential to solving resource challenges in community cancer care.
Digital Innovation and New Drugs Converge to Transform CRM Care
Academic and clinical experts convened in New Haven, Connecticut, on October 30, 2025, to discuss the potential of coordinated care and prevention to manage cardio-renal-metabolic (CRM) disease.
Transforming Population Health for Diabetes and Kidney Disease via Systems of Excellence
Clinicians and health system leaders met in Cleveland, Ohio, on October 23, 2025, to share improvements to value-based care in diabetes and chronic kidney disease.
Expanding Precision Care for Alzheimer Disease, Multiple Sclerosis
Clinicians and health system leaders met in Portland, Oregon, on October 21, 2025, to discuss the evolving options for treating Alzheimer disease and multiple sclerosis.
Innovative Approaches in Academic Neurology Workflows
Experts at an Institute for Value-Based Medicine event held October 14, 2025, in Aurora, Colorado, explored advances in neurology care, cross-specialty collaboration, and strategies to improve access and therapy.
Technology Drives Innovation, Accessibility When Treating Chronic Kidney Disease
Experts met in Park City, Utah, on October 7, 2025, to discuss how new technologies can help address chronic kidney disease.
Redesigning Trials for Real-World Patient Complexity: A Q&A With Prerna Mewawalla, MD
Prerna Mewawalla, MD, discusses innovative strategies to enhance cancer care access, reduce clinician burden, and improve clinical trial diversity in real-world settings.
Managing Cardio-Renal-Metabolic Diseases Requires Multifactorial Approach
Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of managing cardio-renal-metabolic disease.
Precision Medicine Advances Highlight Ongoing Equity Challenges: Tina Bhatnagar, DO
Despite the impact of targeted treatment in oncology, much work remains to bring these therapeutics to all patients, says Bhavana (Tina) Bhatnagar, DO.
Setting the Stage for Collaborative Care to Address CKM Syndrome
Payer and health system leaders convened in Pittsburgh, Pennsylvania, on September 9, 2025, to discuss the interconnected health conditions of cardiovascular-kidney-metabolic (CKM) syndrome.
Emerging Breakthroughs in Neurodegenerative Disease Treatments: Kavita Nair, PhD, FAAN
Kavita Nair, PhD, FAAN, shares how new therapies and ongoing clinical trials are reshaping the future of neurological care and offering new hope to patients.
Barriers and Breakthroughs Ahead for Personalizing Adjuvant Therapy: Michael Hassett, MD
Michael Hassett, MD, explains the evolving landscape of HER2-positive breast cancer treatment and the role of CDK inhibition in personalized therapy strategies.
Postpandemic Breast Cancer Screening Rates Explained: Adam Brufsky, MD, PhD
Adam Brufsky, MD, PhD, addresses how the COVID-19 pandemic affected breast cancer screening rates across Pittsburgh.
How Academic Medical Centers Address Neurological Care: Kavita Nair, PhD, FAAN
Kavita Nair, PhD, FAAN, discusses academic medical centers' unique role in diagnosing and managing neurodegenerative diseases.
How Pharmacists Expand Rural Cancer Care Access: Jasmine Eugene, PharmD
Jasmine Eugene, PharmD, explains how pharmacists practicing at the top of their license improve rural oncology access and ease physician workload.
Telemedicine’s Role in Bridging Cancer Care Gaps: Clark Alsfeld, MD
Clark Alsfeld, MD, discusses how telemedicine, pharmacists, and evolving policies help overcome financial and geographic barriers in oncology care.
Pharmacy Is Essential to Navigating Breast Cancer Treatment: Danielle Roman, PharmD, BCOP
Danielle Roman, PharmD, BCOP, discusses the challenges of accessing genomic test results and managing prior authorization in patient care for breast cancer.
Diet, Lifestyle Come Into Focus for Managing Multiple Sclerosis: Rebecca Spain, MD
Diet and wellness impact multiple sclerosis management, enhancing quality of life and reducing fatigue through lifestyle changes and holistic approaches.
